Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD)

Beth A. Conlon, Jeannette M. Beasley, Karin Aebersold, Sunil S. Jhangiani, Judith Wylie-Rosett

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Nonalcoholic fatty liver disease (NAFLD) is an emerging global health concern. It is the most common form of chronic liver disease in Western countries, affecting both adults and children. NAFLD encompasses a broad spectrum of fatty liver disease, ranging from simple steatosis (NAFL) to nonalcoholic steatohepatitis (NASH), and is strongly associated with obesity, insulin resistance, and dyslipidemia. First-line therapy for NAFLD includes weight loss achieved through diet and physical activity. However, there is a lack of evidenced-based dietary recommendations. The American Diabetes Association's (ADA) recommendations that aim to reduce the risk of diabetes and cardiovascular disease may also be applicable to the NAFLD population. The objectives of this review are to: (1) provide an overview of NAFLD in the context of insulin resistance, and (2) provide a rationale for applying relevant aspects of the ADA recommendations to the nutritional management of NAFLD.

Original languageEnglish (US)
Pages (from-to)4093-4114
Number of pages22
JournalNutrients
Volume5
Issue number10
DOIs
StatePublished - Oct 11 2013

Fingerprint

fatty liver
insulin resistance
Insulin Resistance
diabetes
liver diseases
Liver Diseases
dietary recommendations
hyperlipidemia
Fatty Liver
Dyslipidemias
Non-alcoholic Fatty Liver Disease
physical activity
cardiovascular diseases
Weight Loss
obesity
Chronic Disease
Cardiovascular Diseases
weight loss
Obesity
Exercise

Keywords

  • Diabetes
  • Hepatic steatosis
  • Insulin resistance
  • Macronutrients
  • Nonalcoholic fatty liver disease
  • Nonalcoholic steatohepatitis
  • Nutrition
  • Review

ASJC Scopus subject areas

  • Food Science

Cite this

Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD). / Conlon, Beth A.; Beasley, Jeannette M.; Aebersold, Karin; Jhangiani, Sunil S.; Wylie-Rosett, Judith.

In: Nutrients, Vol. 5, No. 10, 11.10.2013, p. 4093-4114.

Research output: Contribution to journalArticle

Conlon, Beth A. ; Beasley, Jeannette M. ; Aebersold, Karin ; Jhangiani, Sunil S. ; Wylie-Rosett, Judith. / Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD). In: Nutrients. 2013 ; Vol. 5, No. 10. pp. 4093-4114.
@article{b449a21cbffe49ffad45adb0b62c1a8a,
title = "Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD)",
abstract = "Nonalcoholic fatty liver disease (NAFLD) is an emerging global health concern. It is the most common form of chronic liver disease in Western countries, affecting both adults and children. NAFLD encompasses a broad spectrum of fatty liver disease, ranging from simple steatosis (NAFL) to nonalcoholic steatohepatitis (NASH), and is strongly associated with obesity, insulin resistance, and dyslipidemia. First-line therapy for NAFLD includes weight loss achieved through diet and physical activity. However, there is a lack of evidenced-based dietary recommendations. The American Diabetes Association's (ADA) recommendations that aim to reduce the risk of diabetes and cardiovascular disease may also be applicable to the NAFLD population. The objectives of this review are to: (1) provide an overview of NAFLD in the context of insulin resistance, and (2) provide a rationale for applying relevant aspects of the ADA recommendations to the nutritional management of NAFLD.",
keywords = "Diabetes, Hepatic steatosis, Insulin resistance, Macronutrients, Nonalcoholic fatty liver disease, Nonalcoholic steatohepatitis, Nutrition, Review",
author = "Conlon, {Beth A.} and Beasley, {Jeannette M.} and Karin Aebersold and Jhangiani, {Sunil S.} and Judith Wylie-Rosett",
year = "2013",
month = "10",
day = "11",
doi = "10.3390/nu5104093",
language = "English (US)",
volume = "5",
pages = "4093--4114",
journal = "Nutrients",
issn = "2072-6643",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "10",

}

TY - JOUR

T1 - Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD)

AU - Conlon, Beth A.

AU - Beasley, Jeannette M.

AU - Aebersold, Karin

AU - Jhangiani, Sunil S.

AU - Wylie-Rosett, Judith

PY - 2013/10/11

Y1 - 2013/10/11

N2 - Nonalcoholic fatty liver disease (NAFLD) is an emerging global health concern. It is the most common form of chronic liver disease in Western countries, affecting both adults and children. NAFLD encompasses a broad spectrum of fatty liver disease, ranging from simple steatosis (NAFL) to nonalcoholic steatohepatitis (NASH), and is strongly associated with obesity, insulin resistance, and dyslipidemia. First-line therapy for NAFLD includes weight loss achieved through diet and physical activity. However, there is a lack of evidenced-based dietary recommendations. The American Diabetes Association's (ADA) recommendations that aim to reduce the risk of diabetes and cardiovascular disease may also be applicable to the NAFLD population. The objectives of this review are to: (1) provide an overview of NAFLD in the context of insulin resistance, and (2) provide a rationale for applying relevant aspects of the ADA recommendations to the nutritional management of NAFLD.

AB - Nonalcoholic fatty liver disease (NAFLD) is an emerging global health concern. It is the most common form of chronic liver disease in Western countries, affecting both adults and children. NAFLD encompasses a broad spectrum of fatty liver disease, ranging from simple steatosis (NAFL) to nonalcoholic steatohepatitis (NASH), and is strongly associated with obesity, insulin resistance, and dyslipidemia. First-line therapy for NAFLD includes weight loss achieved through diet and physical activity. However, there is a lack of evidenced-based dietary recommendations. The American Diabetes Association's (ADA) recommendations that aim to reduce the risk of diabetes and cardiovascular disease may also be applicable to the NAFLD population. The objectives of this review are to: (1) provide an overview of NAFLD in the context of insulin resistance, and (2) provide a rationale for applying relevant aspects of the ADA recommendations to the nutritional management of NAFLD.

KW - Diabetes

KW - Hepatic steatosis

KW - Insulin resistance

KW - Macronutrients

KW - Nonalcoholic fatty liver disease

KW - Nonalcoholic steatohepatitis

KW - Nutrition

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=84885920935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885920935&partnerID=8YFLogxK

U2 - 10.3390/nu5104093

DO - 10.3390/nu5104093

M3 - Article

C2 - 24152749

AN - SCOPUS:84885920935

VL - 5

SP - 4093

EP - 4114

JO - Nutrients

JF - Nutrients

SN - 2072-6643

IS - 10

ER -